145 related articles for article (PubMed ID: 24005135)
1. The molecular and clinicopathologic characteristics of bilateral breast cancer.
Chen SF; Du CW; Yang P; Zhang HW; Kwan M; Zhang GJ
Sci Rep; 2013; 3():2590. PubMed ID: 24005135
[TBL] [Abstract][Full Text] [Related]
2. Bilateral breast cancer.
Gogas J; Markopoulos C; Skandalakis P; Gogas H
Am Surg; 1993 Nov; 59(11):733-5. PubMed ID: 8239195
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathogenesis of bilateral breast cancer.
Imyanitov EN; Hanson KP
Cancer Lett; 2003 Feb; 191(1):1-7. PubMed ID: 12609703
[TBL] [Abstract][Full Text] [Related]
4. Synchronous bilateral breast cancer: a nationwide study on histopathology and etiology.
Mejdahl MK; Wohlfahrt J; Holm M; Knoop AS; Tjønneland A; Melbye M; Kroman N; Balslev E
Breast Cancer Res Treat; 2020 Jul; 182(1):229-238. PubMed ID: 32441019
[TBL] [Abstract][Full Text] [Related]
5. Bilateral breast cancer, synchronous and metachronous; differences and outcome.
Jobsen JJ; van der Palen J; Ong F; Riemersma S; Struikmans H
Breast Cancer Res Treat; 2015 Sep; 153(2):277-83. PubMed ID: 26268697
[TBL] [Abstract][Full Text] [Related]
6. Systemic investigations into the molecular features of bilateral breast cancer for diagnostic purposes.
Imyanitov EN; Kuligina ES
Expert Rev Mol Diagn; 2020 Jan; 20(1):41-47. PubMed ID: 31835926
[No Abstract] [Full Text] [Related]
7. High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas.
Iyevleva AG; Kuligina ESh; Mitiushkina NV; Togo AV; Miki Y; Imyanitov EN
Breast Cancer Res Treat; 2012 Feb; 131(3):1049-59. PubMed ID: 22057972
[TBL] [Abstract][Full Text] [Related]
8. Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias.
Suspitsin EN; Sokolenko AP; Togo AV; Lazareva YR; Turkevich EA; Matsko DE; Henrich KO; Borresen-Dale AL; Schwab M; Cornelisse CJ; Imyanitov EN
Int J Cancer; 2007 Jan; 120(2):297-302. PubMed ID: 17066426
[TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow.
Cabioglu N; Sahin A; Doucet M; Yavuz E; Igci A; O Yildirim E; Aktas E; Bilgic S; Kiran B; Deniz G; Price JE
Clin Exp Metastasis; 2005; 22(1):39-46. PubMed ID: 16132577
[TBL] [Abstract][Full Text] [Related]
10. Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers.
Karakas Y; Kertmen N; Lacin S; Aslan A; Demir M; Ates O; Aksoy S; Altundag K
J BUON; 2017; 22(3):623-627. PubMed ID: 28730766
[TBL] [Abstract][Full Text] [Related]
11. [Synchronous bilateral breast cancer: risk factors, diagnosis, histology and treatment].
Marpeau O; Ancel PY; Antoine M; Uzan S; Barranger E
Gynecol Obstet Fertil; 2008 Jan; 36(1):35-44. PubMed ID: 18178120
[TBL] [Abstract][Full Text] [Related]
12. A Retrospective Study on the Clinicopathologic Characteristics and Outcomes of 179 Cases of Synchronous and Metachronous Bilateral Breast Cancer in China.
Jia H; Zheng Y; Wang P; Wei Z; Li X; Fu G; Wang C
Clin Breast Cancer; 2022 Apr; 22(3):e341-e349. PubMed ID: 34728164
[TBL] [Abstract][Full Text] [Related]
13. Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas.
Imyanitov EN; Suspitsin EN; Grigoriev MY; Togo AV; Kuligina ESh; Belogubova EV; Pozharisski KM; Turkevich EA; Rodriquez C; Cornelisse CJ; Hanson KP; Theillet C
Int J Cancer; 2002 Aug; 100(5):557-64. PubMed ID: 12124805
[TBL] [Abstract][Full Text] [Related]
14. A contribution to the natural history of breast cancer. V. Bilateral primary breast cancer: incidence, risks and diagnosis of simultaneous primary cancer in the opposite breast.
Tulusan AH; Ronay G; Egger H; Willgeroth F
Arch Gynecol; 1985; 237(2):85-91. PubMed ID: 4083918
[TBL] [Abstract][Full Text] [Related]
15. Synchronous and metachronous bilateral breast cancer: clinicopathologic characteristics and prognostic outcomes.
Mruthyunjayappa S; Zhang K; Zhang L; Eltoum IA; Siegal GP; Wei S
Hum Pathol; 2019 Oct; 92():1-9. PubMed ID: 31351153
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.
Swain SM; Wilson JW; Mamounas EP; Bryant J; Wickerham DL; Fisher B; Paik S; Wolmark N
J Natl Cancer Inst; 2004 Apr; 96(7):516-23. PubMed ID: 15069113
[TBL] [Abstract][Full Text] [Related]
17. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).
Holm NT; Abreo F; Johnson LW; Li BD; Chu QD
Breast Cancer Res Treat; 2009 Jan; 113(2):293-9. PubMed ID: 18270814
[TBL] [Abstract][Full Text] [Related]
18. Incidence of lobular carcinoma in bilateral breast cancer.
Lewis TR; Casey J; Buerk CA; Cammack KV
Am J Surg; 1982 Dec; 144(6):635-8. PubMed ID: 6293326
[TBL] [Abstract][Full Text] [Related]
19. The risk factors and prognosis of bilateral primary breast cancer: a comparative study with unilateral breast cancer.
Wang T; Liu H; Chen KX; Xun P; Li HX; Tang SC
Oncol Res; 2011; 19(3-4):171-8. PubMed ID: 21473293
[TBL] [Abstract][Full Text] [Related]
20. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis.
Liu Y; Ji R; Li J; Gu Q; Zhao X; Sun T; Wang J; Li J; Du Q; Sun B
J Exp Clin Cancer Res; 2010 Feb; 29(1):16. PubMed ID: 20181250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
